Insider · CIK 0001579464

Schrepfer Robert W

Reports to the SEC for 1 company · BAUDETTE, MN

sec.gov

Transactions

Companies

Filings

CIK

0001579464

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−5,566 sh	$32.68	−$182K	87,477
2020-04-10	ANIPANI PHARMACEUTICALS INCA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+39.8K sh	—	—	93,043
2020-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−396 sh	$43.93	−$17.4K	53,276
2020-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−666 sh	$43.22	−$28.8K	53,672
2020-03-31	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−552 sh	$40.74	−$22.5K	54,338
2020-03-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−1,037 sh	$37.76	−$39.2K	54,890
2019-05-13	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−2,409 sh	$71.13	−$171K	55,927
2019-04-16	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−360 sh	$68.60	−$24.7K	58,336
2019-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−392 sh	$70.50	−$27.6K	58,696
2019-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−659 sh	$70.50	−$46.5K	59,088
2019-03-31	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−546 sh	$70.54	−$38.5K	59,747
2019-03-28	ANIPANI PHARMACEUTICALS INCA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+12.5K sh	—	—	60,293
2019-03-28	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+15.1K sh	—	—	15,064
2019-03-13	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+4,651 sh	$33.00	+$153K	52,493
2019-03-13	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−4,651 sh	$64.43	−$300K	47,842
2019-03-13	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−4,651 sh	—	—	3,846
2019-03-12	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+5,642 sh	$28.76	+$162K	53,484
2019-03-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−5,642 sh	$64.44	−$364K	47,842
2019-03-12	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+1,503 sh	$33.00	+$49.6K	49,345
2019-03-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−1,503 sh	$64.50	−$96.9K	47,842
2019-03-12	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−5,642 sh	—	—	608
2019-03-12	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−1,503 sh	—	—	8,497
2018-09-11	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+28.7K sh	$6.60	+$189K	47,842
2018-09-11	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−28.7K sh	—	—	0
2018-05-22	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−600 sh	$61.88	−$37.1K	19,154
2018-04-16	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−247 sh	$60.21	−$14.9K	19,754
2018-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−391 sh	$57.06	−$22.3K	20,001
2018-04-06	ANIPANI PHARMACEUTICALS INCA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+8,000 sh	—	—	20,392
2018-04-06	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+9,600 sh	—	—	9,600
2018-03-31	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−546 sh	$58.22	−$31.8K	12,392
2018-03-01	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+18.8K sh	$28.76	+$539K	41,590
2018-03-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−5,498 sh	$60.33	−$332K	36,092
2018-03-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−10.8K sh	$61.64	−$666K	25,292
2018-03-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−12K sh	$62.25	−$744K	13,338
2018-03-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−400 sh	$63.07	−$25.2K	12,938
2018-03-01	ANIPANI PHARMACEUTICALS INC · Stock OptionM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−18.8K sh	—	—	6,250
2017-05-22	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−450 sh	$47.01	−$21.2K	22,840
2017-04-17	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−270 sh	$51.22	−$13.8K	23,290
2017-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−427 sh	$51.24	−$21.9K	23,560
2017-03-31	ANIPANI PHARMACEUTICALS INCA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+6,625 sh	—	—	23,987
2017-03-31	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+13.3K sh	—	—	13,250
2016-08-08	ANIPANI PHARMACEUTICALS INCS Sale	SVP - NEW BUS DEV & SPEC SALES	SSale	−12.5K sh	$67.06	−$838K	17,362
2016-05-22	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - NEW BUS DEV & SPEC SALES	FTax Payment	−450 sh	$49.54	−$22.3K	29,862
2016-04-07	ANIPANI PHARMACEUTICALS INCA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+4,750 sh	—	—	30,312
2016-04-07	ANIPANI PHARMACEUTICALS INC · Option to PurchaseA Award	SVP - NEW BUS DEV & SPEC SALES	AAward	+9,500 sh	—	—	9,500
2016-02-18	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+6,000 sh	$6.60	+$39.6K	25,562
2016-02-18	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−6,000 sh	—	—	28,688
2015-06-18	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+9,062 sh	$6.60	+$59.8K	19,562
2015-06-18	ANIPANI PHARMACEUTICALS INC · Option to PurchaseM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	−9,062 sh	—	—	34,688
2015-05-06	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP - NEW BUS DEV & SPEC SALES	MExercise/Conversion	+2,500 sh	$6.60	+$16.5K	10,500

Recent filings

Accepted (ET)
Mar 294
Schrepfer Robert W0001415889-21-001685
SEC(opens sec.gov)
Apr 144
Schrepfer Robert W0001104659-20-046393
SEC(opens sec.gov)
Apr 84
Schrepfer Robert W0001104659-20-044731
SEC(opens sec.gov)
Mar 314
Schrepfer Robert W0001104659-20-041411
SEC(opens sec.gov)
May 134
Schrepfer Robert W0001144204-19-025603
SEC(opens sec.gov)
Apr 184
Schrepfer Robert W0001144204-19-020283
SEC(opens sec.gov)
Apr 94
Schrepfer Robert W0001144204-19-018900
SEC(opens sec.gov)
Apr 24
Schrepfer Robert W0001144204-19-017773
SEC(opens sec.gov)
Apr 14
Schrepfer Robert W0001144204-19-017403
SEC(opens sec.gov)
Mar 144
Schrepfer Robert W0001144204-19-013796
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCSVP - NEW BUS DEV & SPEC SALESANIP

Address

210 MAIN STREET WEST C/O ANI PHARMACEUTICALS, INC.

BAUDETTE, MN, 56623